Viewing Study NCT05245760


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 5:00 PM
Study NCT ID: NCT05245760
Status: WITHDRAWN
Last Update Posted: 2022-11-08
First Post: 2022-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer
Sponsor: Zhonglin Hao
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
None Esophagogastric Junction Cancer View
Keywords: